Related Experiment Videos
Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice
María Nieto1, Francisco J Gil-Bea, Esther Dalfó
1Department of Neurology and Neurosurgery, Clinica Universitaria de Navarra, Universidad de Navarra, Pamplona, Navarre, Spain.
Neurobiology of Aging
|July 12, 2005
Summary
Overexpression of mutant alpha-synuclein A30P in mice increases vulnerability to the neurotoxin MPTP. This suggests a link between genetic mutations and environmental factors in Parkinson's disease pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Toxicology
Background:
- Parkinson's disease (PD) pathogenesis is influenced by both genetic and environmental factors.
- Investigating gene-environment interactions is crucial for understanding PD.
- Alpha-synuclein mutations are implicated in familial PD.
Purpose of the Study:
- To determine if transgenic mice overexpressing mutant human alpha-synuclein A30P (Tg5093) exhibit heightened sensitivity to neurotoxins.
- To assess the interaction between genetic predisposition (mutant alpha-synuclein) and environmental insults (MPTP, rotenone).
Main Methods:
- Tg5093 mice and non-transgenic littermate controls were chronically treated with MPTP or rotenone.
- Neurotoxicity was assessed by quantifying nigral tyrosine hydroxylase (TH)-positive neurons and striatal dopamine (DA) levels.
Main Results:
- Tg5093 mice showed no increased sensitivity to chronic rotenone treatment.
- Chronic MPTP treatment (80 or 150 mg/kg) led to significantly greater deterioration of the nigrostriatal dopaminergic system in Tg5093 mice compared to controls.
- Quantification revealed reduced TH-positive neurons and DA levels in MPTP-treated Tg5093 mice.
Conclusions:
- Overexpression of mutant human alpha-synuclein A30P enhances the vulnerability of dopaminergic neurons to MPTP toxicity.
- This finding supports a role for specific alpha-synuclein mutations in mediating susceptibility to environmental neurotoxins in Parkinson's disease.